Spironolactone and metformin combination therapy as a potential non-hormonal treatment for management of hyperandrogenic symptoms of polycystic ovarian syndrome
Introduction: Polycystic ovarian syndrome (PCOS) is one of the most common endocrinological conditions in women of child-bearing age.1 It is characterised by symptoms of oligo- or anovulation, hyperandrogenism and polycystic ovarian morphology.2 Current mainstay treatment for PCOS involves off-label...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Clinical Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1470211825001794 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!